AstraZeneca announces new initiative for lung cancer screening for American Indian and Alaska Native Communities.

“Bridging the Tribal Inequity Gap to Early Lung Cancer Screening” is an initiative aimed at increasing lung cancer screening rates in American Indian and Alaska Native (AI/AN) communities through a culturally tailored toolkit.

Designed for both healthcare providers and community members, the toolkit raises awareness, shares best practices, and supports improved screening rates in historically underserved populations. This resource directly addresses systemic barriers—including access, trust, and cultural responsiveness—while equipping clinics and communities with practical, relevant educational resources.

For your reference, here is a link to the AstraZeneca American Indian and Alaska Native Lung Cancer Screening Toolkit, which offers culturally relevant resources to support lung cancer screening awareness in Tribal Nations:

AZLungCancerScreeningToolkit.com

AstraZeneca is committed to treating both early- and late-stage lung cancer. By honoring culture, acknowledging history, and working together, our goal is to improve outcomes and strengthen health for future generations.

This effort supports AstraZeneca’s Global Health Equity Goal to impact 1 billion lives, with a focus on underrepresented groups such as American Indian and Alaska Native communities.



No comments have been posted yet.